![]() |
![]() |
![]() |
What Plan Sponsors Need To Know and Do About Upcoming Drug Pricing Changes |
Date/Time:
Cost:
To Register: Description:The overwhelming majority of contracts with pharmacy benefit managers (PBMs) use average wholesale price (AWP) to determine drug pricing with their customers. On March 30, 2009, the U.S. District Court in Massachusetts entered a “Final Order and Judgment” approving a class action settlement with First DataBank (FDB) and Medi-Span, the primary publishers of AWP. The Final Order and Judgment includes a requirement to adjust their AWP price index to “rollback” the markup on approximately 1,400 national drug codes (NDCs). These adjustments are scheduled to occur on September 26, 2009. Independent of the settlement, FDB and Medi-Span also plan to discontinue publishing their AWP index altogether within two years. These are major changes, and challenges, for pharmacy benefit plan sponsors that contract with a PBM. Please join us for this presentation and learn:
|
|
Presenters:ROB NOEL
JOHN HINES, MBA John Hines supports PSG’s data warehousing, reporting, and analytics functions. He has more than 10 years of experience with systems and financial analysis, having held several senior positions with Caremark and CIGNA. John is responsible for the development of advanced data and financial analysis tools. His experience as an analyst of PBM claims data is among the best in the PBM industry and is instrumental to the services PSG provides to its clients. John holds a BS in accounting and an MBA from Northern Arizona University. |
|